BRIEF-Valeant Pharma ups offering to $900 mln from $850 mln principal amount of notes
Nov 18 Valeant Pharmaceuticals International Inc : * Says has priced its offering of 5.625% senior unsecured notes due 2021-SEC
filing * Valeant pharmaceuticals international inc -co increased the offering to $900
million from $850 million aggregate principal amount of notes * Source text () * Further company coverage
UPDATE 6-BA cancels flights from London as global IT outage causes chaos
* BA latest to be hit by computer problems (Adds comment by BA's chief executive)
GM says ISS advises against Greenlight share plan, board nominees
May 27 General Motors Co said on Saturday that proxy advisory firm Institutional Shareholder Services has recommended that shareholders vote against a slate of directors proposed by hedge fund Greenlight Capital and reject the hedge fund's plan to divide GM shares into two classes.